LYTIR

Company · MAR

Marriott International

Name as listed on its exchange; filed with the SEC as MARRIOTT INTERNATIONAL INC /MD/.

Nasdaq's symbol directory lists MAR on Nasdaq as “Marriott International - Class A Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 6 occasions ($33.5M); 7 planned-sale notices; 1 congressional trade disclosure; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 44, No. 43

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $33.5M in total.Sep: Insider sales $3.7MNov: Insider sales $29.8MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $33.5M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Capuano Anthony, President & CEO sold on 1 day latest Nov 4, 2026 sold $26.6M
  2. Reiss Rena Hozore, EVP & General Counsel sold on 1 day latest Nov 4, 2026 sold $2.1M
  3. Harrison Deborah Marriott sold on 1 day latest Sep 25, 2026 sold $1.2M
  4. Marriott David S sold on 1 day latest Sep 25, 2026 sold $1.2M
  5. MARRIOTT J W JR sold on 1 day latest Sep 25, 2026 sold $1.2M
  6. Breland Benjamin T., CHRO & EVP, Global Ops. Serv. sold on 1 day latest Nov 4, 2026 sold $1.1M
Every trade (6)
  1. SELLCapuano Anthony, President & CEO sold Nov 4, 2026 63,355 shares 10 legs combined filing $26.6M
  2. SELLReiss Rena Hozore, EVP & General Counsel sold Nov 4, 2026 4,969 shares 2 legs combined filing $2.1M
  3. SELLBreland Benjamin T., CHRO & EVP, Global Ops. Serv. sold Nov 4, 2026 2,500 shares filing $1.1M
  4. SELLHarrison Deborah Marriott sold Sep 25, 2026 3,500 shares filing $1.2M
  5. SELLMarriott David S sold Sep 25, 2026 3,500 shares filing $1.2M
  6. SELLMARRIOTT J W JR sold Sep 25, 2026 3,500 shares filing $1.2M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Anthony Capuano filed Nov 4, 2026 President / CEO / Director 57,750 shares planned sale date 11/04/2026 filing $24.0M
  2. Capuano Anthony filed Nov 4, 2026 Officer 5,605 shares planned sale date 11/04/2026 filing $2.4M
  3. Reiss Rena Hozore filed Nov 4, 2026 Officer 4,969 shares planned sale date 11/04/2026 filing $2.1M
  4. Breland Benjamin T. filed Nov 4, 2026 Officer 2,500 shares planned sale date 11/04/2026 filing $1.1M
  5. Marriott David S filed Sep 25, 2026 Chairman of the Board 3,500 shares planned sale date 09/25/2026 filing $1.2M
  6. MARRIOTT J W JR filed Sep 25, 2026 Chairman Emeritus 3,500 shares planned sale date 09/25/2026 filing $1.2M
  7. Harrison Deborah Marriott filed Sep 25, 2026 Board Member 3,500 shares planned sale date 09/25/2026 filing $1.2M

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 2, 2026
  2. Entry into a material definitive agreement; Creation of a direct financial obligation filing Sep 24, 2026
  3. Other events filing Aug 13, 2026
  4. Results of operations and financial condition filing Aug 3, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.